Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing

被引：0
|
作者：
Laurent Kodjikian
Lluís Arias Barquet
András Papp
Peter J. Kertes
Edoardo Midena
Jan Ernest
Rufino Silva
Thomas Schmelter
Tobias Niesen
Sergio Leal
机构：
[1] Croix-Rousse Teaching Hospital,Department of Ophthalmology
[2] Hospices Civils de Lyon,UMR
[3] Université Claude Bernard Lyon 1,CNRS 5510 Matéis, Villeurbanne
[4] University of Lyon,Department of Ophthalmology
[5] Hospital Universitario de Bellvitge,Department of Ophthalmology
[6] University of Barcelona,Department of Ophthalmology
[7] Semmelweis University,Department of Ophthalmology and Vision Sciences
[8] The John and Liz Tory Eye Centre,Department of Ophthalmology
[9] Sunnybrook Health Sciences Centre,Coimbra Institute for Clinical and Biomedical Research Faculty of Medicine (iCBR
[10] University of Toronto,FMUC)
[11] University Hospital,Ophthalmology Department
[12] Axon Clinical Research Center,undefined
[13] University of Coimbra,undefined
[14] Centro Hospitalar e Universitário de Coimbra (CHUC),undefined
[15] Association for Innovation and Biomedical Research on Light and Image (AIBILI),undefined
[16] Clinical Academic Center of Coimbra (CACC),undefined
[17] Bayer AG,undefined
[18] Bayer Consumer Care AG,undefined
来源：
Advances in Therapy | 2024年 / 41卷
关键词：
Anatomic outcomes; Anti-vascular endothelial growth factor; Fixed dosing; Functional outcomes; Intravitreal aflibercept; Neovascular age-related macular degeneration; Treat-and-extend; Treatment burden; Treatment interval;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1010 / 1024
页数：14
相关论文
共 50 条
  • [21] Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration
    Ross, Adam H.
    Downey, Louise
    Devonport, Helen
    Gale, Richard P.
    Kotagiri, Ajay
    Mahmood, Sajjad
    Mehta, Hemal
    Narendran, Niro
    Patel, Praveen J.
    Parmar, Nina
    Jain, Nitin
    EYE, 2020, 34 (10) : 1825 - 1834
  • [22] Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration
    Adam H. Ross
    Louise Downey
    Helen Devonport
    Richard P. Gale
    Ajay Kotagiri
    Sajjad Mahmood
    Hemal Mehta
    Niro Narendran
    Praveen J. Patel
    Nina Parmar
    Nitin Jain
    Eye, 2020, 34 : 1825 - 1834
  • [23] Comment on ‘Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results’
    V P Dave
    Eye, 2015, 29 : 1630 - 1630
  • [24] One-year results of treat-and-extend regimen with intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration
    Hidetaka Matsumoto
    Junki Hoshino
    Kosuke Nakamura
    Hideo Akiyama
    Japanese Journal of Ophthalmology, 2024, 68 : 83 - 90
  • [25] Efficacy of Intravitreal Aflibercept Treat-and-Extend Regimen Over 2 Years for Neovascular Age-Related Macular Degeneration: ARIES Study
    Souied, Eric H.
    Holz, Frank G.
    Hykin, Philip G.
    Midena, Edoardo
    Wolf, Sebastian
    Allmeier, Helmut
    Mitchell, Paul
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [26] Three-year Outcomes of Treat and Extend Aflibercept Treatment for Neovascular Age-related Macular Degeneration
    Kataoka, Keiko
    Asai, Keiko
    Tsunekawa, Yuma
    Ito, Yasuki
    Terasaki, Hiroko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [27] One-year results of treat-and-extend regimen with intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration
    Matsumoto, Hidetaka
    Hoshino, Junki
    Nakamura, Kosuke
    Akiyama, Hideo
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2024, 68 (02) : 83 - 90
  • [28] Two-Year Outcomes of Treat-and-Extend Intravitreal Aflibercept for Exudative Age-Related Macular Degeneration A Prospective Study
    Maruko, Ichiro
    Ogasawara, Masashi
    Yamamoto, Akiko
    Itagaki, Kanako
    Hasegawa, Taiji
    Arakawa, Hisaya
    Nakayama, Makiko
    Koizumi, Hideki
    Okada, Annabelle A.
    Sekiryu, Tetsuju
    Iida, Tomohiro
    OPHTHALMOLOGY RETINA, 2020, 4 (08): : 767 - 776
  • [29] Efficacy and safety of intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E) compared with fixed dosing (q8) for neovascular age-related macular degeneration (nAMD): The AZURE study
    Kodjikian, Laurent
    Arias Barquet, Lluis
    Papp, Andras
    Kertes, Peter
    Midena, Edoardo
    Ernest, Jan
    Silva, Rufino
    Schmelter, Thomas
    Niesen, Tobias
    Leal, Sergio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [30] Two year results of intravitreal aflibercept injections for neovascular age-related macular degeneration using a treat and extend regimen
    Hosokawa, Mio
    Morizane, Yuki
    Kimura, Shuhei
    Hosogi, Mika
    Doi, Shinichiro
    Shiraga, Fumio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
12345